Should Exogenous Ketone Body Supplementation Be Considered in Patients Hospitalized for Acute Heart Failure? Rationale and Design of the KETO-AHF Trial
Kristoffer Berg‐Hansen(Aarhus University), Henrik Wiggers(Aarhus University), Pardeep S. Jhund(Copenhagen University Hospital), Morten Bøttcher(Aarhus Municipality), Andreas Bugge Tinggaard(Aarhus University Hospital), Søren Vraa(Aalborg University Hospital), Anders Hostrup Larsen(Aarhus University), Nigopan Gopalasingam(Aarhus University Hospital), Lisbeth Antonsen(Odense University Hospital), Mikael Kjær Poulsen(Odense University Hospital), Emil Wolsk(Gentofte Hospital), Roni Nielsen(Aarhus University), Malene Hollingdal, Toru Kondo(Nagoya University), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Morten Schou(Copenhagen University Hospital), Jacob Eifer Møller(University of Southern Denmark), Jens Dahlgaard Hove(Hvidovre Hospital), Niels Møller(Aarhus University), Thomas Jensen(Aarhus University Hospital), Barry A Borlaug(Mayo Clinic), Johannes Grand(Jisc)
Cited by 1
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k